Twist Bioscience and the BioBricks Foundation Announce First-of-its-Kind Partnership to Provide 10,000 Public-Benefit Genes to the Synthetic Biology Community
SAN FRANCISCO, June 15, 2017 /PRNewswire/ — Twist Bioscience, a company accelerating science and innovation through rapid, high-quality DNA synthesis, and the BioBricks Foundation today announced a groundbreaking agreement to provide 10,000 genes to the synthetic biology community. Under the terms of the agreement, the BioBricks Foundation (BBF) will pay for synthesis of 10,000 genes from... Read more